ACC |
American College of Cardiology |
ACE |
angiotensin I-converting enzyme |
ACS |
acute coronary syndrome |
ADP |
P2Y12 receptor: adenosine 5′diphosphate P2Y12 receptor |
AHA |
American Heart Association |
APTT |
activated partial thromboplastin time |
aPL |
antiphospholipid |
APS |
antiphospholipid syndrome |
ARDS |
acute respiratory distress syndrome |
CAD |
coronary artery disease |
Cit-H3 |
citrullinated histone H3 |
CTC |
cardiac thrombotic complication |
CVD |
cardiovascular disease |
COVID-19 |
coronavirus disease 2019 |
CYP3A4 |
cytochrome P450 3A4 |
CYP2C19 |
Cytochrome P450 2C19 |
CRP |
C-reactive protein |
DIC |
disseminated intravascular coagulation |
DILI |
drug-induced liver injury |
dsDNA |
double-stranded DNA |
ESC |
European Society of Cardiology |
ICU |
intensive care unit |
IL |
interleukine |
INR |
international normalized ratio |
MI |
myocardial infarction |
MPO-DNA |
myeloperoxidase-DNA |
NADPH |
nicotinamide adenine dinucleotide phosphate |
NETs |
neutrophil extracellular traps. |
PAI-1 |
plasminogen activator inhibitor 1 |
PCI |
percutaneous coronary intervention |
PE |
pulmonary embolism |
PT |
prothrombin time |
RAAS |
renin-angiotensin-aldosterone system |
RUCAM |
Roussel Uclaf Causality Assessment Method |
SARS-CoV-2 |
severe acute respiratory syndrome-coronavirus-2 |
SIRS |
systemic inflammatory response syndrome |
STEMI |
ST elevation myocardial infarction |
TED |
thromboembolic disease |
TNF |
tumor necrosis factor |
TT |
thrombin time |